{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:22:17Z","timestamp":1763468537848,"version":"3.44.0"},"reference-count":25,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,10,23]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>Isoniazid preventative therapy is widely used for latent tuberculosis infection. Isoniazid is highly effective but has many adverse effects, including neuropsychiatric. We describe the case of an 80-year-old woman with mania. She had received isoniazid preventative therapy during steroid treatment for rheumatoid arthritis and organising pneumonia for the previous 5\u2009months. Her mania resolved after discontinuation of isoniazid. Adverse effects of isoniazid should be considered even if a long time has elapsed since the start of administration. Physicians other than infectious disease and respiratory specialists also must be aware of the adverse effects of isoniazid preventative therapy.<\/jats:p>","DOI":"10.1136\/bcr-2019-231919","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T10:09:33Z","timestamp":1572689373000},"page":"e231919","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Mania induced by isoniazid preventive therapy during steroid treatment for rheumatoid arthritis and organising pneumonia"],"prefix":"10.1136","volume":"12","author":[{"given":"Hiroyuki","family":"Nagano","sequence":"first","affiliation":[{"name":"Emergency Medicine and General Internal Medicine, Rakuwakai Marutamachi Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto Okamoto Memorial Hospital, Kuze-gun, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ueda","sequence":"additional","affiliation":[{"name":"Emergency Medicine and General Internal Medicine, Rakuwakai Marutamachi Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,11,2]]},"reference":[{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.1","DOI":"10.1007\/s11920-000-0030-6"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.2","DOI":"10.1183\/09031936.00120908"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.3","DOI":"10.1056\/NEJMra1405427"},{"key":"2025082800320480000_12.11.e231919.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.5","DOI":"10.1183\/13993003.01245-2015"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.6","DOI":"10.1086\/313891"},{"key":"2025082800320480000_12.11.e231919.7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/DHPS.S68837","article-title":"Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study","volume":"6","author":"Denholm","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"key":"2025082800320480000_12.11.e231919.8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-Associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.9","DOI":"10.1016\/j.psym.2011.12.007"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.10","DOI":"10.1517\/14740338.5.2.231"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.11","DOI":"10.2165\/11534340-000000000-00000"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.12","DOI":"10.7326\/0003-4819-101-1-92"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.13","DOI":"10.4103\/0019-5545.82567"},{"key":"2025082800320480000_12.11.e231919.14","first-page":"406","article-title":"Psychiatric side effects of nonpsychiatric drugs","volume":"3","year":"1971","journal-title":"Semin Psychiatry"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.15","DOI":"10.1097\/00006565-200202000-00008"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.16","DOI":"10.1016\/j.rmed.2006.01.014"},{"key":"2025082800320480000_12.11.e231919.17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5530\/ijopp.10.2.29","article-title":"Isoniazid associated psychosis: a case series of 3 patients","volume":"10","author":"Menon","year":"2017","journal-title":"IJOPP"},{"key":"2025082800320480000_12.11.e231919.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018507","article-title":"Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey","volume":"6","author":"Sabbagh","year":"2011","journal-title":"PLoS One"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.19","DOI":"10.1053\/jhep.2002.32102"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.20","DOI":"10.1056\/NEJMoa1714283"},{"unstructured":"World Health Organization . Global tuberculosis report, 2018. Available: https:\/\/www.who.int\/tb\/publications\/global_report\/en\/ [Accessed 05 Jul 2019].","key":"2025082800320480000_12.11.e231919.21"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.22","DOI":"10.1016\/S2352-3018(16)30087-X"},{"doi-asserted-by":"publisher","key":"2025082800320480000_12.11.e231919.23","DOI":"10.1681\/ASN.2014101017"},{"unstructured":"Hirotomo A . \"Recommendations for the challenges and the further development of the bio-pharmaceutical industry\". Available: http:\/\/www.jpma.or.jp\/opir\/research\/rs_071\/article_071.html [Accessed 05 Jul 2019].","key":"2025082800320480000_12.11.e231919.24"},{"unstructured":"The Research Institute of tuberculosis\/JATA, The Tuberculosis Surveilance Center . \"Transition of latent tuberculosis infection notifications by months\".. Available: http:\/\/www.jata.or.jp\/rit\/ekigaku\/toukei\/nenpou\/ [Accessed 05 Jul 2019].","key":"2025082800320480000_12.11.e231919.25"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-231919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:32:16Z","timestamp":1756366336000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-231919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,2]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bcr-2019-231919"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-231919","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}